Filing Flows › Maravai Lifesciences Holdings (MRVI) › Stock forecast & fair value
Maravai Lifesciences Holdings (MRVI) stock forecast and price target
Maravai Lifesciences Holdings (MRVI) trades at $7.52. 6 analysts' median price target is $8.00 (+6%), from $7.00 to $12.00.
Maravai Lifesciences Holdings' latest quarter
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for MRVI stock?
The median of 6 analysts' 12-month targets is $8.00, +6% from $7.52; the range is $7.00 to $12.00. The average rating is buy.
Does Maravai Lifesciences Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is MRVI stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.